XML 59 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1
Discontinued Operations - Key Financial Results (Details) - Infectious Disease Business - Disposal Group, Disposed of by Sale, Not Discontinued Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]    
Net product revenues $ (26) $ 6,751
Cost of product revenue 214 3,575
Research and development 412 11,983
Selling, general and administrative 3,096 22,725
Total operating expenses 3,722 38,283
Income (loss) from operations (3,748) (31,532)
Gain from sale of business 168,955 0
Other expense, net (74) (120)
Income (loss) from discontinued operations before income taxes 165,133 (31,652)
Benefit for income taxes 51,148 22
Income (loss) from discontinued operations, net of tax $ 113,985 $ (31,674)